当前位置:肿瘤瞭望>资讯>快讯>正文

第14届圣加仑国际乳腺癌大会初步学术日程一览(中英文对照)

作者:肿瘤瞭望   日期:2015/2/10 17:46:55  浏览量:22785

肿瘤瞭望版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

第14届圣加仑国际乳腺癌大会初步学术日程

2015年3月18日

国际癌症预防协会(ISCaP)工作会议
主持:Powel H. Brown
Introduction: Preventing all forms of breast cancer 讲者:Powel H. Brown
导言:预防所有形式的乳腺癌
Prevention of ER-positive breast cancer 讲者:Mangesh Thorat
ER阳性乳腺癌的预防
Novel strategies to prevent ER-negative breast cancer 讲者:Powel H. Brown
预防ER阴性乳腺癌的新策略
Breast cancer vaccines 讲者:Nora Disis
乳腺癌疫苗
Conclusion 讲者:Jack Cuzick
总结
14:30-15:30 Opening ceremony and conferment of St.Gallen International Breast Cancer Award 2015
开幕式和2015年圣加仑国际乳腺癌奖颁奖仪式
Welcome on behalf of St.Gallen Oncology Conferences (SONK) and International Breast Cancer Study Group (IBCSG) 讲者:Hans-Joerg Senn
SONK和IBCSG代表致欢迎词
Welcome on behalf of Austrian Breast Cancer Study Group (ABCSG) 讲者:Michael Gnant
奥地利乳腺癌研究组代表致欢迎词
Conferment of St.Gallen Breast Cancer Award 2015  
2015年圣加仑乳腺癌奖颁奖
15:00 Opening address by the St. Gallen 2015 Award winner
圣加仑乳腺癌奖2015得主开幕致辞
The evolution of the St.Gallen consensus process for the optimal treatment of women with breast cancer 讲者:Alan S. Coates
圣加伦乳腺癌妇女最佳治疗共识形成过程的演变
15:30-17:00 Session 1: News since St. Gallen 2013
议程1:2013St.Gallen会议以来的新进展
主持: Alan S. Coates,Hans-Joerg Senn
Surgical management of early breast cancer 2015 讲者:Monica Morrow
2015年早期乳腺癌的外科治疗
Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification in early versus late recurrences 讲者:Daniel F. Hayes
遗传学特征在选择辅助治疗中的临床应用:早期复发和晚期复发的风险分层
Picking the optimal endocrine adjuvant treatment for pre-menopausal women 讲者:Marco Colleoni
为绝经前妇女选择最佳内分泌辅助治疗
Big data: Are large prospective randomized trials obsolete in the future? 讲者:Clifford Hudis
大数据:大型前瞻性随机试验在未来会过时吗?
讨论  
17:30-18:45 Session 2: Biology of breast cancer I: Bridging the gap between high throughput technologies and breast cancer treatment in real life
议程2:乳腺癌生物学I:缩小高通量技术与乳腺癌实际治疗之间的差距
主持:C. Kent OsborneBeat Thürlimann
Interpreting genomics data at a functional level: What are we learning from large molecular screening projects? 讲者:Peter Campbell
从功能层面解释基因组学数据:我们从大型分子筛查项目中能学到什么?
Deep genomic analysis and treatment decisions based on genomic-driven and pathway-matched therapies 讲者:Fabrice André
基于基因组学驱动、通路匹配的治疗方案进行深层次基因组学分析和治疗决策
Discrepancies between genetic tools and immunohistochemistry: Bad pathology and good signature, and vice-versa 讲者:Jorge S. Reis-Filho
遗传学工具和免疫组化之间的不一致:病理结果差而遗传特征好,或反之
A bad tumor biomarker is as bad as a bad drug: The gap between genomics data and phenotype to predict response 讲者:Giuseppe Viale
劣质肿瘤生物学标志物和劣效药物一样糟糕:预测应答时基因组学数据和表型的差距
讨论  

 

 

2015年3月19日

 

8:30-9:45 Session 3: Biology of breast cancer II: Tumor heterogeneity and disease segmentation in breast cancer
议程3:乳腺癌生物学II:乳腺癌的肿瘤异质性和疾病划分
主持:Fraser W. SymmansJonas Bergh
Intratumor heterogeneity: Targeting multiple trunk and branch drivers in breast cancer 讲者:Charles Swanton
肿瘤内异质性:靶向于乳腺癌的多个主要和次要驱动因素
Heterogeneity of Triple Negative subtype: Gene expression profile and phenotype 讲者:Brian D. Lehmann
三阴性乳腺癌的异质性:基因表达谱和表型
Molecular segmentation in Luminal breast cancer: How to select the driver pathways 讲者:Sherene Loi
luminal型乳腺癌的分子分类:如何选择驱动通路
Insights in biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implications 讲者:Nadja Harbeck
思考luminal HER-2与富集HER-2亚型之间的生物学特征:对治疗的启示
讨论  
9:45-10:45 Session 4: Biology of breast cancer III: Genome remodeling and tumor microenvironment
议程4:乳腺癌生物学III:基因组重构和肿瘤微环境
主持:Mitch DowsettDaniel F. Hayes
Tumor-stroma crosstalk: Targeting stroma and inflammation 讲者:Frances Balkwill
肿瘤与基质的相互作用:靶向于基质和炎症
Immune-pathways and immunome as a target 讲者:Giuseppe Curigliano
可作为目标的免疫通路和免疫组
Targeting bone microenvironment: Clinical implications 讲者:Michael Gnant
靶向于骨微环境:临床启示
讨论  
11:20-12:30 Session 5: Bridging clinic with biology: Emerging drugable pathways on the horizon
议程5:链接临床和生物学:药物开发即将成功的通路
主持:Giuseppe CuriglianoClifford Hudis
Targeting CDK 4-6 pathway 讲者:Richard S. Finn
靶向CDK4-6通路
Targeting DNA repair pathways 讲者:Andrew Tutt
靶向DNA修复通路
Targeting PIK3CA pathway 讲者:José Baselga
靶向PIK3CA通路
Targeting FGFR pathway 讲者:Nicholas Turner
靶向FGFR通路
讨论  
14:00-15:00 Session 6: Primary prevention, metabolism and genetics
议程6:一级预防,代谢和遗传学
主持:John F. ForbesMarco Colleoni
Using germline genetics in the management of breast cancer patients and their families 讲者:Judy Garber
利用生殖细胞遗传学管理乳腺癌患者及其亲属
Preventing invasive breast cancer in women at high risk based on benign/in situ pathology 讲者:Jack Cuzick
基于良性或原位病变预防高危女性侵袭性乳腺癌的发生
Obesity and insulin resistance: Correlations and time course of prognostic associations 讲者:Pamela J. Goodwin
肥胖和胰岛素抵抗:与预测作用的关系和时间进程
讨论  
15:00-16:15 Session 7: Beyond pathology of breast cancer in 2015
议程7:乳腺癌病理学在2015年的新拓展
主持:Giuseppe Viale; Hervé Bonnefoi
The special case of “equivocal” pathological biomarkers (ER, PgR and HER2): Implications for breast cancer treatment 讲者:Fraser W. Symmans
病理学标志物模棱两可的特殊案例(ERPgRHER-2):对乳腺癌治疗的启示
BCL-2: A new therapeutic target in estrogen receptor-positive breast cancer? 讲者:Geoffrey J. Lindeman
BCL-2:雌激素受体阳性乳腺癌的新治疗靶点?
The changing role of ER in endocrine resistance 讲者:C. Kent Osborne
ER在内分泌耐药中的角色转变
Developing Ki-67 as a useful marker 讲者:Carsten Denkert
Ki-67开发成为有用标志物
讨论  
16:45-18:00 Session 8: Primary systemic therapy of early breast cancer
议程8:早期乳腺癌的一线全身治疗
主持:Eric Winer; Giuseppe Curigliano
Primary systemic therapy for clinicians: Medical and research perspectives 讲者:Sybille Loibl
临床医生从医疗和研究角度看待一线全身治疗
Clinical usefulness and relevance of intermediate endpoints for cytotoxic primary systemic therapy 讲者:Gunter von Minckwitz
细胞毒性一线全身治疗的中期终点临床应用和意义
Clinical trial designs in the neoadjuvant setting: Challenges of the genomic era 讲者:Lisa Carey
新辅助治疗的临床试验设计:来自基因组时代的挑战
讨论  

 

 

2015年3月20日

8:30-10:00 Session 9: Areas of controversy in surgery of early breast cancer, in special populations
议程9:特殊人群早期乳腺癌手术治疗的争议
主持:Michael GnantMasakazu Toi
Optimal surgical management for high risk populations 讲者:Tari King
高危人群的最佳外科管理方法
Surgical management after neoadjuvant chemotherapy 讲者:Peter Dubsky
新辅助化疗后的外科管理
Conservative surgery for multifocal/multicentric disease 讲者:Emiel J.T. Rutgers
多病灶/多中心乳腺癌的保守手术
Breast conservative surgery and local recurrence 讲者:Mahdi Rezai
乳腺保守手术和局部复发
讨论  
10:00-11:00 Session 10: Radiotherapy: Innovation and long term effects in early breast cancer
议程10:放射治疗:在早期乳腺癌中的创新和长期疗效
主持:Roberto OrecchiaFelix Sedlmayer
Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues 讲者:John Yarnold
早期乳腺癌低分割放疗在临床、剂量测定和放射基因组学等方面存在的问题
Evolving Standards in Breast Cancer Radiotherapy: Who Should Receive Locoregional RT? 讲者:Timothy Whelan
乳腺癌放疗标准的演变:哪些患者应进行局部放疗?
Technical innovation in adjuvant radiotherapy: Evolution and evaluation of new treatments for today and tomorrow 讲者:Ian Kunkler
新辅助放疗的技术革新:当前和未来新治疗方法的演变和评估
讨论  
11:30-12:30 Session 11: Adjuvant systemic treatment for individual patients I: Endocrine therapies: New aspects for old treatments
议程11:辅助全身治疗的个体化应用I:内分泌治疗-老方法的新应用
主持:James N. IngleKathleen I. Pritchard
Endocrine therapy for premenopausal women: Type and duration 讲者:Nancy Davidson
绝经前妇女的内分泌治疗:类型和疗程
Endocrine therapy for post-menopausal patients: Type and duration 讲者:Harold Burstein
绝经后患者的内分泌治疗:类型和疗程
Predicting benefit of endocrine therapy 讲者:Meredith Regan
预测内分泌治疗的获益
讨论  
14:00-15:30 Session 12: Adjuvant systemic treatment for the individual patient II: Cytotoxic chemotherapy and targeted agents
议程12:辅助全身治疗的个体化应用II:细胞毒性化疗和靶向药物
主持:Ian SmithSybille Loibl
Tailoring the chemotherapy regimen in patients with triple negative subtypes 讲者:Eric Winer
为三阴性乳腺癌患者度身定做化疗方案
Defining optimal duration and predicting benefit from chemo-therapy in patients with luminal-like subtypes 讲者:Angelo Di Leo
luminal样亚型患者定义最佳化疗疗程并预测获益
Targeting HER2 in 2015 讲者:Martine Piccart-Gebhart
HER-2治疗在2015年的前景
Long term side effects of adjuvant chemotherapy in patients with early breast cancer 讲者:Antonio Wolff
早期乳腺癌患者辅助化疗的长期不良反应
讨论  
16:00-17:15 Session 13: Adjuvant systemic treatment for the individual patient III: Special patient populations and patient needs
议程13:辅助全身治疗的个体化应用iii:特殊类型患者和患者需求
主持:Martine Piccart-GebhartBent Ejlertsen
Management of breast cancer in very young women 讲者:Ann Partridge
年轻乳腺癌女性患者的管理
Management of breast cancer in older and frail patients 讲者:Ian Smith
老年和体弱乳腺癌患者的管理
Survivorship care after early breast cancer 讲者:Stella Kyriakidis
早期乳腺癌康复患者的管理
讨论  

 

2015年3月21日

 

8:30-12:30 Session 14: St. Gallen international consensus session on the optimal primary treatment of breast cancer
议程14:St. Gallen乳腺癌最佳一线治疗国际共识会议
主持:Aron Goldhirsch,Eric Winer
秘书:Giuseppe Curigliano
 

版面编辑:张楠  责任编辑:何豫

本内容仅供医学专业人士参考


乳腺癌大会学术日程

分享到: 更多